LCAR-M61D

· The First Affiliated Hospital with Nanjing Medical University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LCAR-M61D, covering 2024-06-28 to 2024-06-28. Get the full timeline:

Most recent: Clinical Trial Update: LCAR-M61S and LCAR-M61D in Treatment of Relapsed/Refractory Multiple Myeloma [NA]